4616 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
21 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
22 Recruiting Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
23 Completed Chronic Kidney Disease Prevention of An-Lo District, Keelung
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Death
Intervention: Behavioral: multidisciplinary predialysis education
24 Recruiting Pilot Study of Velcade® in IgA Nephropathy
Conditions: Chronic Kidney Disease;   IgA Nephropathy
Intervention: Drug: Bortezomib (Velcade®)
25 Completed Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease;   Diabetes Type 2
Intervention: Drug: N-acetylcysteine
26 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
27 Completed Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease (CKD) Patients Receiving Chronic Hemodialysis
Conditions: End Stage Renal Disease;   Chronic Kidney Disease
Intervention: Drug: Soluble Ferric Pyrophosphate in liquid bicarbonate
28 Completed Olmesartan Medoxomil and Diabetic Nephropathy
Conditions: Type 2 Diabetes Mellitus;   Diabetic Nephropathy;   Proteinuria;   Renal Disease
Interventions: Drug: Olmesartan medoxomil;   Drug: Losartan
29 Recruiting Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
Conditions: Chronic Kidney Disease Stage 3;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
30 Suspended Pediatric Chronic Kidney Disease Safety and Efficacy
Conditions: Chronic Kidney Disease;   Hyperparathyroidism;   Hyperparathyroidism, Secondary;   Kidney Disease;   Secondary Hyperparathyroidism
Interventions: Drug: cinacalcet capsule;   Drug: placebo capsule;   Drug: cinacalcet tablet;   Drug: placebo tablet
31 Unknown  Risk Stratification in End Stage Renal Disease (ESRD)
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Cardiovascular Event;   Sudden Cardiac Death
32 Completed Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
Conditions: Chronic Kidney Disease;   Kidney Disease
Intervention: Drug: De Novo Administration of Darbepoetin Alfa
33 Completed
Has Results
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Interventions: Drug: Zemplar (paricalcitol ) capsules;   Drug: Zemplar (paricalcitol) capsules;   Drug: Placebo
34 Recruiting Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
35 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
36 Completed Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Type 2 Diabetes;   Diabetic Nephropathy
Interventions: Other: Placebo;   Drug: Bardoxolone Methyl (RTA 402)
37 Recruiting Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
Conditions: End Stage Renal Disease;   Kidney Disease;   Protein Energy Wasting
Interventions: Drug: PINTA 745;   Drug: Placebo
38 Completed 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
39 Recruiting Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Conditions: Blood Coagulation Disorders;   Atrial Fibrillation;   Thrombosis of Left Atrial Appendage;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
Intervention: Device: Left atrial appendage occlusion
40 Recruiting PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease
Conditions: Chronic Kidney Disease;   Diabetes
Intervention: Drug: darbepoetin alfa

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years